The allosteric AKT inhibitor, MK2206, decreases tumor growth and invasion in patient derived xenografts of endometrial cancer. (Q52799875)
Jump to navigation
Jump to search
scientific article published on 23 January 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The allosteric AKT inhibitor, MK2206, decreases tumor growth and invasion in patient derived xenografts of endometrial cancer. |
scientific article published on 23 January 2017 |
Statements
The allosteric AKT inhibitor, MK2206, decreases tumor growth and invasion in patient derived xenografts of endometrial cancer. (English)
1 reference
Abigail Winder
1 reference
Kenji Unno
1 reference
Yanni Yu
1 reference
John Lurain
1 reference
J Julie Kim
1 reference
23 January 2017
1 reference
18
1 reference
958-964
1 reference
12
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference